Product Name | MF | CAS | Details |
---|
MK-8245 | C16H15BrFN7O3S | 1030612-87-3 | Details |
NVP-HSP990(HSP990) | C20H18FN5O2 | 934343-74-5 | Details |
LY-573636 | C11H5BrCl2NNaO3S2 | 519055-63-1 | Details |
Nepicastat hydrochloride | C14H16ClF2N3S | 170151-24-3 | Details |
BiMatoprost IMpurity III | C25H35NO4 | 1163135-96-3 | Details |
AST-1306 | C31H26ClFN4O5S | 1050500-29-2 | Details |
3-[(1S,2S)-2-Hydroxycyclohexyl]-6-[(6-methyl-3-pyridinyl)methyl]benzo[h]quinazolin-4(3H)-one | C25H25N3O2 | 1227923-29-6 | Details |
KX1-004 | C16H13FN2O2 | 518058-84-9 | Details |
(S)-2-[(S)-(4-Nitro-phenoxy)-phenoxy-phosphorylaMino]propionic acid Isopropyl ester | C18H21N2O7P | 1256490-49-9 | Details |
XEN445 | C18H17F3N2O3 | 1515856-92-4 | Details |
1-(2-DIPHENYLMETHOXYETHYL)-4-(3-PHENYLPROPYL)PIPERAZINE DIHYDROCHLORIDE | C28H35ClN2O | 67469-81-2 | Details |
17-PHENYL TRINOR PROSTAGLANDIN E2 | C23H30O5 | 38315-43-4 | Details |
BMS-345541 | C14Cl1H18N5 | 547757-23-3 | Details |
SINOVA SL-02580 | C22H22N4O4 | 357263-13-9 | Details |
16-(3-chlorophenoxy)-17,18,19,20-tetranorprostaglandin F2 alpha | C22H29ClO6 | 40665-93-8 | Details |
EPOXOMICIN | C28H50N4O7 | 134381-21-8 | Details |
trans (15S)-Latanoprost | C26H40O5 | 1235141-39-5 | Details |
(15R)-BiMatoprost | C25H37NO4 | 1163135-92-9 | Details |
CHIR-124 | C23H22ClN5O | 405168-58-3 | Details |
Erteberel (LY500307) | C18H18O3 | 533884-09-2 | Details |
4SC-201 | C16H19N3O4S | 864814-88-0 | Details |
(R)-2-((R)-6,7-diMethoxy-1-(4-(trifluoroMethyl)phenethyl)-3,4-dihydroisoquinolin-2(1H)-yl)-N-Methyl-2-phenylacetaMide | C29H31F3N2O3 | 913358-93-7 | Details |
AZD3514 | C25H32F3N7O2 | 1240299-33-5 | Details |
NITD 609 | C19H14Cl2FN3O | 1193314-23-6 | Details |
5-Heptenoic acid, 7-[(1S,2S,3S,5R)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-4-[3-(trifluoroMethyl)phenoxy]-1-buten-1-yl]cyclopentyl]-, 1-Methylethyl ester, (5Z)- | C26H35F3O6 | 340181-93-3 | Details |
Ribociclib | C23H30N8O | 1211441-98-3 | Details |
(S)-tert-butyl (1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl)carbaMate | C22H24FN3O3 | 870281-85-9 | Details |
SALUBRINAL | C21H17Cl3N4OS | 405060-95-9 | Details |
CIS,CIS,CIS-TETRAKIS(DIPHENYLPHOSPHINOMETHYL)CYCLOPENTANE | C57H54P4 | 333380-86-2 | Details |
SL 327 | C16H12F3N3S | 305350-87-2 | Details |
ansamitocin P-3 | C32H43ClN2O9 | 66584-72-3 | Details |
IDOXIFENE | C28H30INO | 116057-75-1 | Details |
Tavaborole | C7H6BFO2 | 174671-46-6 | Details |
Crisaborole | C14H10BNO3 | 906673-24-3 | Details |
XL888 | C29H37N5O3 | 1149705-71-4 | Details |
(+)-Cloprostenol isopropyl ester | C25H35ClO6 | 157283-66-4 | Details |
(S)-2-(1-aMinopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one | C17H16FN3O | 870281-86-0 | Details |
GSK 525762A | C22H22ClN5O2 | 1260907-17-2 | Details |
TP808 | C26H34N2O5Si | 852821-06-8 | Details |
[4-[[5-Chloro-4-(MethylaMino)-2-pyriMidinyl]aMino]-3-Methoxyphenyl]-4-MorpholinylMethanone | C17H20ClN5O3 | 1351758-81-0 | Details |
BMS 833923 | C30H27N5O | 1059734-66-5 | Details |
Avermectin A1a, 25-cyclohexyl-4-O-de(2,6-dideoxy-3-O-methyl-.alpha.-L-arabino-hexopyranosyl)-5-demethoxy-25-de(1-methylpropyl)-22,23-dihydro-5-(hydroxyimino)- | C43H63NO11 | 165108-07-6 | Details |
Rucaparib | C19H18FN3O | 283173-50-2 | Details |
inolitazone | C27H26N4O4S | 223132-37-4 | Details |
ON-01910 | C21H26NNaO8S | 1225497-78-8 | Details |
2-Cyclopentyl-4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl-benzoicacid | C25H22N2O2 | 890842-28-1 | Details |
(5E)-BiMatoprost | C25H37NO4 | 1163135-95-2 | Details |
Narlaprevir | C36H61N5O7S | 865466-24-6 | Details |
N-[4-[(2-Amino-3-chloropyridin-4-yl)oxy]-3-fluorophenyl]-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide | C25H19ClF2N4O4 | 1025720-94-8 | Details |
N,N'-Bis(2-bromoethyl)phosphorodiamidic acid (1-methyl-2-nitro-1H-imidazol-5-yl)methyl ester | C9H16Br2N5O4P | 918633-87-1 | Details |
JIB-04 | C17H13ClN4 | 199596-05-9 | Details |
Oclacitinib | C15H23N5O2S | 1208319-26-9 | Details |
5-(2-BENZOTHIAZOLYL)-3-ETHYL-2-(-(METHY | C31H27N4S.I | 681281-88-9 | Details |
tasquinimod | C20H17F3N2O4 | 254964-60-8 | Details |
A-740003 | C26H30N6O3 | 861393-28-4 | Details |
Lersivirine(UK 453061) | C17H18N4O2 | 473921-12-9 | Details |
AMG 458 | C30H29N5O5 | 913376-83-7 | Details |
Didesethyl flurazepam dihydrochloride | C17H17Cl3FN3O | 19603-97-5 | Details |
QS11 | C36H33N5O2 | 944328-88-5 | Details |
Genz-123346 | C24H38N2O4 | 491833-30-8 | Details |
7-[(1R,2S)-2-[(1E,3S,5S)-3-Hydroxy-5-Methyl-1-nonenyl]-5-oxo-3-cyclopenten-1-yl]-2-heptenoic Acid | C22H34O4 | 853998-94-4 | Details |
NSC 42834 | C23H24N2O | 195371-52-9 | Details |
XMD17 109 | C36H46N8O3 | 1435488-37-1 | Details |
NSC697923 | C11H9NO5S | 343351-67-7 | Details |
TELMESTEINE | C7H11NO4S | 122946-43-4 | Details |
TROXACITABINE | C8H11N3O4 | 145918-75-8 | Details |
AZD1152 | C26H31FN7O6P | 722543-31-9 | Details |
2,2'-[[Dihydro-2-(4-pyridinyl)-1,3(2H,4H)-pyrimidinediyl]bis(methylene)]bis[N,N-dimethylbenzenamine | C27H35N5 | 500579-04-4 | Details |
Dabrafenib Mesylate | C24H24F3N5O5S3 | 1195768-06-9 | Details |
6-AMINO-4-(4-PHENOXYPHENYLETHYLAMINO)QUINAZOLINE | C22H20N4O | 545380-34-5 | Details |
AG 490 | C17H14N2O3 | 134036-52-5 | Details |
5-[[(1,1'-BIPHENYL)-4-YL]METHYL]-N,N-DIMETHYL-1H-TETRAZOLE-1-CARBOXAMIDE | C17H17N5O | 874902-19-9 | Details |
IRAK-1/4 INHIBITOR I | C20H21N5O4 | 509093-47-4 | Details |
Cetuximab | C107H179N35O36S7 | 205923-56-4 | Details |
7-[Trans-3-(1-Azetidinylmethyl)cyclobutyl]-5-[3-(phenylmethoxy)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine | C27H29N5O | 475488-34-7 | Details |
ARRY-424704, ARRY-704 | C16H17FIN3O4 | 869357-68-6 | Details |
Amg 517 | C20H13F3N4O2S | 659730-32-2 | Details |
IWR-1-endo | C25H19N3O3 | 1127442-82-3 | Details |
Paliperidone Palmitate | C39H57FN4O4 | 199739-10-1 | Details |
Dovitinib Lactate | C24H27FN6O4 | 692737-80-7 | Details |
1-PropanesulfonaMide, N-[3-[(5-broMo-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl]- | C17H14BrF2N3O3S | 918504-27-5 | Details |
N-[3-[(4aS,7aS)-2-Amino-5,7-dihydro-4H-furo[3,4-d][1,3]thiazin-7a(4aH)-yl]-4-fluorophenyl]-5-fluoro-2-pyridinecarboxamide hydrochloride | C18H16F2N4O2S.HCl | 1262036-49-6 | Details |
XL-647 | C24H25Cl2FN4O2 | 781613-23-8 | Details |
Glasdegib | C21H22N6O | 1095173-27-5 | Details |
FLI-06 | C25H30N2O5 | 313967-18-9 | Details |
MK-886 | C27H34ClNO2S | 118414-82-7 | Details |
Beraprost | C24H30O5 | 88430-50-6 | Details |
(Z)-methyl 3-((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenylamino)(phenyl)methylene)-2-oxoindoline-6-carboxylate | C31H33N5O4 | 1160294-26-7 | Details |
BMS-599626 | C27H28ClFN8O3 | 873837-23-1 | Details |
Ro 3306 | C18H13N3OS2 | 872573-93-8 | Details |
7,10-Bis-O-(2,2,2-trichloroethoxycarbonyl)-10-deacetylbaccatin III | C35H38Cl6O14 | 95603-44-4 | Details |
LY2801653 | C30H22F2N6O3 | 1206799-15-6 | Details |
ARRY-543 | C29H27ClN6O5S2 | 1146629-86-8 | Details |
MLN-120B | C19H15ClN4O2 | 783348-36-7 | Details |
diMethyl 3-(benzyloxy)-4-oxo-4H-pyran-2,5- | C16H14O7 | 1246616-66-9 | Details |
Entospletinib (GS-9973) | C23H21N7O | 1229208-44-9 | Details |
BMS-791325 | C36H46ClN5O5S | 958002-36-3 | Details |
Product Total: Product Page: | ||||
1 2 3 4 5 6 |